Pharmacogenomics Results Affect Patients' Plan of Care and Changes in Medication Prescription(s)

NCT03322189 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2019-01-23

No results posted yet for this study

Summary

Current providers' standard operating procedures on pharmacogenomic testing patients

Conditions

  • Pharmacogenomic

Interventions

GENETIC

pharmacogenomic

Standard Operating Procedures on Pharmacogenomic testing and changes made to specific SOP

Sponsors & Collaborators

  • PAS Research Services

    collaborator OTHER
  • Data Collection Analysis Business Management

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-03-22
Primary Completion
2020-03-22
Completion
2020-04-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03322189 on ClinicalTrials.gov